{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Lake Forest",
      "state": "IL",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "69013",
      "recalling_firm": "Akorn, Inc.",
      "address_1": "1925 W. Field Court, Suite 300",
      "address_2": "N/A",
      "postal_code": "60045",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-1571-2014",
      "product_description": "Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass vials, Rx only For IV Infusion only, individually boxed, Mfd. for: Akorn, Inc., Lake Forest, IL --- NDC 17478-151-42",
      "product_quantity": "5,539 vials",
      "reason_for_recall": "Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl impurity at the 22 month stability time point",
      "recall_initiation_date": "20140805",
      "center_classification_date": "20140922",
      "termination_date": "20150521",
      "report_date": "20141001",
      "code_info": "Lot: 12RIF4A, Expiration Date: 9/30/2014"
    }
  ]
}